Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
22.83
+0.10 (0.44%)
Feb 11, 2026, 4:00 PM EST - Market closed
Zymeworks Employees
Zymeworks had 263 employees as of September 30, 2025. The number of employees decreased by 31 or -10.54% compared to the same quarter last year.
Employees
263
Change
-31
Growth
-10.54%
Revenue / Employee
$511,335
Profits / Employee
-$241,167
Market Cap
1.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 263 | -31 | -10.54% | 263 | 0 |
| Jun 30, 2025 | 273 | -17 | -5.86% | 273 | 0 |
| Mar 31, 2025 | 299 | 24 | 8.73% | 299 | 0 |
| Dec 31, 2024 | 286 | 8 | 2.88% | 280 | 6 |
| Sep 30, 2024 | 294 | 42 | 16.67% | 294 | 0 |
| Jun 30, 2024 | 290 | 53 | 22.36% | 290 | 0 |
| Mar 31, 2024 | 275 | -29 | -9.54% | 275 | 0 |
| Dec 31, 2023 | 278 | -16 | -5.44% | 272 | 6 |
| Sep 30, 2023 | 252 | -34 | -11.89% | 252 | 0 |
| Jun 30, 2023 | 237 | -47 | -16.55% | 237 | 0 |
| Mar 31, 2023 | 304 | -23 | -7.03% | 304 | 0 |
| Dec 31, 2022 | 294 | -164 | -35.81% | 291 | 3 |
| Sep 30, 2022 | 286 | -169 | -37.14% | 286 | 0 |
| Jun 30, 2022 | 284 | -141 | -33.18% | 284 | 0 |
| Mar 31, 2022 | 327 | -56 | -14.62% | 327 | 0 |
| Dec 31, 2021 | 458 | 103 | 29.01% | 455 | 3 |
| Sep 30, 2021 | 455 | 130 | 40.00% | 455 | 0 |
| Jun 30, 2021 | 425 | 130 | 44.07% | 425 | 0 |
| Mar 31, 2021 | 383 | 116 | 43.45% | 383 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 493 |
| MannKind | 407 |
| Ardelyx | 395 |
| Vericel | 357 |
| Nurix Therapeutics | 317 |
| Tango Therapeutics | 155 |
| Precigen | 143 |
| Innoviva | 127 |
ZYME News
- 15 days ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Zymeworks Inc. (ZYME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy - GlobeNewsWire
- 4 weeks ago - HERIZON-GEA-01 Trial Highlights Zymeworks' Path To $440M Milestones And Growth - Seeking Alpha
- 4 weeks ago - Zymeworks Outlines Strategic Priorities and Outlook for 2026 - GlobeNewsWire
- 5 weeks ago - Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit - GlobeNewsWire
- 2 months ago - Zymeworks Inc. (ZYME) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Zymeworks Announces Participation in Upcoming Conferences - GlobeNewsWire